Last Friday, MEDSIR’s office hosted a meeting for the I3LUNG partners: Vall d’Hebron Institute of Oncology (VHIO), Universitätsklinikum Hamburg Eppendorf, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Istituto Mario Negri and MEDSIR, represented by Caterina Carbonell Núñez, Aina Bursá, Rocío Caro Consuegra, Ronald Simon, MELISSA FERNANDEZ PINTO, Alba Meya Molina, Ramon Amat Ferrer, Monica Ganzinelli, Laura Brunelli and Cecilia Silvestri.
During this working session, the team shared initial results from the first phase of patient analysis and conducted an in-depth brainstorming session focused on integrating innovative techniques to advance the project. They also discussed progress on the OMICs platform and established a timeline for potential results communications in 2025.
Go, go, GOOO I3LUNG project 💙🫁
During the session on “Ethical and Regulatory Aspects for Implementing AI in Clinical Trials,” Arsela Prelaj, our I3LUNG partner from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, delivered a talk on “AI for Immuno-Oncology.”
Her presentation highlighted how artificial intelligence is driving advancements in personalized cancer treatments and shaping the future of immunotherapy. A huge step forward for the I3LUNG project and AI-driven solutions in clinical research!
I3LUNG made an appearance at “Cancer Core Europe’s Summer School in Translational Cancer Research 2024”, in Albufeira (Portugal). On October 9, the project was showcased in the AI for oncology session, as one of the use cases presented by Arsela Prelaj to present how AI tools are used for prediction and treatment decision. The week-long event regrouped 70 junior researchers with backgrounds from basic to clinical and computational research.
Arsela Prelaj has presented I3LUNG project during the “Building Bridges to Interconnect People 2024 meeting“, a yearly Italian digital meeting and training event for clinical oncologists aimed at sharing the latest innovations in the fields of diagnostic and treatment.
The project was explained during the October 1st session on “Unlocking the potential of artificialIntelligence in cancer research and care”, with an overview of the wide range of activities conducted by the I3LUNG consortium for the creation of co-decision tools.
During the 125th Congresso Nazionale di Oncologia, held from October 11th to 13th, Francesco Trovò, from our partner Politecnico di Milano, presented advancements in his talk titled “L’Intelligenza Artificiale in Oncologia” that are making a real difference in cancer treatment.
Trovò explained how AI techniques are helping predict the effectiveness of immunotherapy treatments in patients with non-small cell lung cancer. This technology is not only allowing treatments to be tailored to each patient’s specific needs, but also improving the precision of clinical trials and enhancing predictive capabilities.
Thank you, Francesco, and the POLIMI team for your participation in the congress!
Today, on World Mental Health Day, the I3LUNG project emphasizes the importance of mental health. Since the project’s inception, we have consistently focused on patient well-being, recognizing mental health as a vital aspect of our research.
I3LUNG is developing an AI-based program that supports patients in treatment decision-making and enhances communication with their doctors, helping to reduce some of the emotional stress that comes with a lung cancer diagnosis.
Listen to Valeria Sebri from the European Institute of Oncology as she discusses the significance of mental health in the context of cancer care.
Last Thursday, 12th of September, MEDSIR organized an insightful event titled “10 Years from Now – The Future of Breast and Lung Cancer: Reflections After a Decade of Research.” Experts from diverse fields gathered to share their perspectives on the advancements in cancer research and treatment.
Alfonso Aguarón from Lung Cancer Europe provided valuable insights from a patient’s point of view, while Dr. Arsela Prelaj from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano discussed the application of artificial intelligence (AI) in medicine, specifically in the I3LUNG project.
The event also featured leading oncology experts such as Dr. Antonio Llombart Cussac, Senior Scientific Lead at MEDSIR, Maria Jose Martinez Serrano, Medical Head of Solid Tumors at Novartis España, and Pilar Fernández Pascual, President of the Asociación Española Cáncer de Mama Metastásico. Together, they offered a 360º view on the present and future of cancer research and treatment.
Another day, another partner going all out.
Massimo Broggini, Head Department of Experimental Oncology, from Istituto Mario Negri participated in the internal seminar on artificial intelligence (AI) titled “L’intelligenza artificiale nella ricerca clinica e pre-clinica,” held in Milan on September 4th.
During the event, advances in the use of AI in clinical and preclinical research were discussed. In the segment “Le esperienze nell’uso dell’Intelligenza artificiale presso il Mario Negri,” Dr. Broggini presented the I3LUNG project, which focuses on applying artificial intelligence to improve the treatment and management of lung cancer.
Thank you, Massimo and the Istituto Mario Negri, for your role in the I3LUNG project.
On June 21st and 22nd 2024, under the warm hospitality of the partner Metropolitan Hospital (MH), we celebrated the third Annual Meeting of the I3LUNG project on the beautiful island of Spetses, Greece. This event brought together the 15 partners who shared their progress in this exciting stage of research.
The event began on the afternoon of Friday, the 21st, following an enriching scientific workshop attended by several of our partners. Helena Linardou (from MH), warmly welcomed us, followed by the inspiring words of Arsela Prelaj from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano PI of the I3LUNG.
After few presentations, we enjoyed a delicious Greek snack during the break, a moment we used to reconnect with our colleagues, whom we hadn’t seen since the last Annual Meeting in Barcelona in 2023. We also took advantage of the breaks to conduct some interviews, capturing valuable insights from our partners.
After a short break, we returned full of energy for the discussions that followed. The end of Friday’s agenda had to be postponed to Saturday because we ran out of time to continue.
The day ended with a dinner in an authentic Greek restaurant, where we celebrated the two years of the I3LUNG project with a delicious cake, music, and lots of fun.
On Saturday, the 22nd, we kicked off the meeting at 9:30 AM, continuing with discussions and presentations. We had the honor of hearing Mireia Crispin Ortuzar, Assistant Professor in Cambridge & Chief Digital Officer in 52 North, who provided valuable insights on multimodal integration intointo the project.
Finally, after an intense morning of work, we concluded the Annual Meeting at 2 PM, preparing for a boat excursion around different spots on the island. Could we have ended the meeting on a better note? We don’t think so!
We said goodbye to this wonderful gathering, looking forward to the next one, which will be… Can you guess where? We are excited to see each other faces again soon!
Stay tuned for all the I3LUNG updates on our social media channels and do not hesitate to contact us for more information.
Francesco Trovò from Politecnico di Milano participated in the L’intelligenza artificiale in Sanità event organized by the Università di Siena, where he shared significant advancements of the I3LUNG project.
In his presentation titled “AI in Oncology: Insights and Guidelines from Real Case Studies“, Francesco had the opportunity to showcase how artificial intelligence is transforming the field of oncology.
During his talk he highlighted the impact of I3LUNG on oncological research and how emerging technologies are optimizing treatments and improving outcomes for patients. The presentation provided valuable insights into the practical applications of AI in oncology, supported by real-life cases demonstrating the effectiveness of these innovations.